Implementation of Capacitance Probes for Continuous Viable Cell Density Measurements for 2K Manufacturing Fed-Batch Processes at Biogen Idec

Similar documents
Single Use Capacitance Measurements of Viable Cell Volume

BioPAT ViaMass Real-time, Inline Biomass Measurement for Cell Culture Processes in single-use. 03 May 2013 Page 1

High throughput cell culture technology as a route to improved process understanding. Seth Rodgers, CTO Bioprocessors Jan 29, 2007

Thermo Scientific HyCell CHO Medium: Targeted for high cell density and productivity across a broad variety of CHO clones

Efficient operation of the HyPerforma 5:1 Single-Use Bioreactor at low working volume

Scaling Down Bioreactor Process Development: Comparison of Microbioreactor and Bench Scale Solutions.

Thermo Scientific Metabolic Pathway Design Process Cell culture media and process optimization approaches for optimal biotherapeutic production

Eden Approach To Bioprocess Characterisation. Philip Mellors p USP Development & Transfer Team Leader

Rapid selection of high yielding GS-CHO cell lines using the GS expression system in a protein-free, chemically defined, animal component-free process

Abstract. Materials and Methods. Introduction

MEASURMENT OF THE FILM THICKNESS, FILM VELOCITY AND ENTRAINMENT FRACTION IN A LIQUID-AIR ANNULAR FLOW USING A CONDUCTANCE FLOWMETER

A Quality-by-Design Approach to Upstream Bioprocess Interrogation and Intensification

Accelerate Bioprocess Development Using the Modular Automated Sampling Technology (MAST ) Platform

Efficient operation of the HyPerforma 5:1 Single-Use Bioreactor at low working volume

Development of high-yielding chemically defined and animal component-free generic processes using GS cell lines. David Mainwaring, Lonza Biologics

BalanCD HEK293 SYSTEM

BalanCD HEK293 SYSTEM

Development of a fed batch process using Cell Boost supplements

Automated Monitoring of CAR-T Cells in a Rocking Motion Bioreactor

One-step seed culture expansion from one vial of high-density cell bank to 2000 L production bioreactor

Challenges in Scaling Up Newly Developed Microbial Manufacturing Processes

ProCellics. In-Line & Real-Time Bioprocess Raman Analyzer

In the current competitive biopharmaceutical

Single use plastic settlers for clarifying cell culture broth, selective removal of dead cells and affinity capture of antibodies on protein A beads

Efficient and controlled expansion of IgG1 producing CHO-DG44 cells using the ActiCHO Media System and WAVE Bioreactor

BD Resurge Media Supplements Chemically Defined. Protein Free. Animal Free.

From gene to manufacturing: Application of efficient cell line development strategies to deliver reliable, high quality biomanufacturing processes

Improving Single Use Bioreactor Design and Process Development: New Research Towards Intensifying Seed- Train and Scale-Up Methods Using 5:1 Turn-Down

Extended Life Tantalum Hybrid Capacitor

Bioreactors and Fermenters. Biometrix Corporation (800)

Application Note. Increased efficiency and product quality with the UniVessel Single Use bioreactor for CHO fed-batch cultures.

Batch Record: Anti-IL-8 mab Production from CHO DP-12 Cells Lot Number

Alternatives to Optimize Gas Processing Operations

Hollow Fiber Bioreactors Product Line Introduction

Hollow Fiber Bioreactors: Single-Use. Perfusion. Scalable. Continuous Manufacturing.

RECENT IMPROVEMENTS TO LONZA S GLUTAMINE SYNTHETASE (GS) GENE EXPRESSION SYSTEM. Dr Robert Gay

User Manual. Version 1.0 THERMISTOR CHARACTERISTICS TRAINER. Model No : (ITB - 06ACE)

2.7 Calibrating soil water monitoring devices

39 Acid base titration: Alanine (HA2) (2- aminopropanoic acid) with sodium hydroxide

ab Cell Viability Assay Kit Fluorometric Dual Green/Red

is kept at a minimum with low power densities of less than 50 mw/cm 2.

The Application of Low Energy MBR in Landfill Leachate Treatment

Quality Control in clinical laboratory. Kanit Reesukumal, M.D. Assistant Professor Clinical Pathology Mahidol University

Scientific Considerations for Continuous Manufacturing Processes

CM4120 Chemical Pilot Operations Lab Bioprocess (Fermentation) Experiment. Presentation Outline

Outline. Upstream Processing: Development & Optimization

Chemically Defined CHO Media Test Panel Consultation Service

APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION

Training Program 2019

Analytical Instrumentation for Wastewater Monitoring

TransGuard. AVX Multilayer Ceramic Transient Voltage Suppressors GENERAL DESCRIPTION TRANSGUARD DESCRIPTION

De-ionized water. Nickel target. Supplementary Figure S1. A schematic illustration of the experimental setup.

BIOSTAT B-DCU. Product Presentation. Page 1

Assessing and Managing Strategic Risk for Next Generation Processes of Established Brands Eric R. Garr Associate Director, Global Product Development

ENCAPSULATION OF ORGANIC LIGHT EMITTING DIODES

Application of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013

Supporting Information for Facile fabrication of nanofluidic diode membranes using anodic aluminum oxide

Cellca Technology Platform

CHO-GSN PLATFORM STABLE CELL LINE GENERATION. NR v5

Example Protocol for the Culture of the SW620 Cell Line on Alvetex Scaffold in Well Insert and Well Plate Formats

Mark Hahn, Ron Smith, Milton Watts Q uartzdyne Electronics

Earlier Lecture. In the earlier lecture, we have seen the importance of instrumentation in Cryogenic Engineering.

On the dielectric method of monitoring cellular viability

Inspection. Implementation of ICH Q8, Q9, Q10

G-Rex Instructions for Use

OPTIMIZATION OF MICROWAVE HEATING IN AN EXISTING CUBICLE CAVITY BY INCORPORATING ADDITIONAL WAVE GUIDE AND CONTROL COMPONENTS

2015 AQ Summit: Research Update by Peter Van Walsum

Rent a Bioreactor. Bioreactor & Fermentation Technology at acib

Evaluation of potential PAT tools

2.4 TYPES OF MICROBIAL CULTURE

Common Issues in Qualification and Validation of Analytical Procedures

Philadelphia College of Osteopathic Medicine Annual Progress Report: 2010 Formula Grant

ph Sensor Recalibration Based on Exhaust CO 2 Concentration for Bioprocess Transfer and Scaling

Uninterruptible Power Supply

Labfors 5. THE HIGH-END ALL-ROUNDER. We bring life to your laboratory.

Business Cases Based on Negative CO2 emissions

ATPlite Assay Performance in Human Primary Cells

AquaNereda Aerobic Granular Sludge Technology

Standard Operating Procedure for the Determination of Specific Conductance CCAL 11A.2

MODELLING AND SIMULATION OF BUILDING ENERGY SYSTEMS USING INTELLIGENT TECHNIQUES

Use in Process Characterization. Nathan McKnight

Dried Blood Spot Analysis From The Clinic To The Laboratory

MEDIUM FREQUENCY WELDING

Supplemental Data for California Smart Thermostat Work Paper

Pipe Flow Hydraulics

Servicing Class D Amplifiers

Advanced Robotic GMAW Cladding Process Development. November 6 th and 7 th, 2013

APPLICATION OF DIELECTRIC SPECTROSCOPY IN AN INDUSTRIAL BIOPROCESS UTILIZING THE BACULOVIRUS EXPRESSION VECTOR SYSTEM ALEXANDER BRIX

THE PREDICTION OF THE CELL AND SUBSTRATE IN A FED-BATCH FERMENTATION SYSTEM BY MODIFICATION OF MODELS (Date received: )

Enhancing Product Quality through CM An Industry Perspective for Transitioning CM from Technology Evaluation to a Default Manufacturing Platform

Mitigating Commercial Risks in Continuous Manufacturing Drug Product

Utilization of the Labcyte MicroClime Environmental Lid to Reduce Edge Effects in a Cell-based Proliferation Assay

Utilization of the Labcyte MicroClime Lid to Reduce Edge Effects in a Cell-based Proliferation Assay

Lifecycle of NIR Analytical Methods: Regulatory Perspective

Cultivation of aggressive microbial cultures of Pichia and Bacillus using the HyPerforma 30 L and 300 L Single-Use Fermentors

Titerless Infected-cells Preservation and Scale-up (TIPS) David J. Wasilko & S. Edward Lee Pfizer Global Research & Development Groton, CT

Figure 15 Periodic annual increment (PAI) and gross mean annual increment (MAI) in basal area per acre by treatments for (A) Skykomish treatments 1,

Evidence of dependence between crop vigor and yield

Keeping ahead in biopharmaceutical manufacturing

Cedex Bio HT Analyzer as a tool for high-throughput analysis for fast physiological characterization of microbial bioprocesses

Transcription:

Implementation of Capacitance Probes for Continuous Viable Cell Density Measurements for 2K Manufacturing Fed-Batch Processes at Biogen Idec Jason Wong (Manufacturing Sciences, Cambridge) IFPAC January 24, 2014

Outline Introduction Technology Implementation Strategy Example: Process X Commercial Manufacturing Process 2

Introduction Viable cell density (VCD) is an important parameter Measured off-line through periodic sampling On-line VCD monitoring benefits to manufacturing: 1) Continuous monitoring of VCDs at bioreactor stages 2) Track growth based on historical performance and troubleshoot growth excursions in real-time manner 3) Reduced sampling 4) Transfer cell culture within seed train bioreactors 3

Technology Dielectric spectroscopy (Harris et al., 1987, Kell et al. 1990; and Yardley et al., 2000) Measures the dielectric properties of the medium as a function of frequency Suspension of cells composed of three separate parts: 1. Medium 2. Cytoplasm 3. Plasma Membrane (Non-Conducting) Electrically speaking, Cell Suspension = Suspension of spherical capacitors each containing a conducting matrix and all surrounded by a conducting medium 4

Probe Theory Positive Electrode + Medium + + + _ + _ + Plasma Membrane (Poor Conductor) + _ + + _ Negative Electrode Cytoplasm _ Applied electric field results in + ions pushed in direction of field and ions in opposite direction Ions accumulate along this membrane resulting in polarization at poles of cells Magnitude of suspension s field can be measured by its capacitance (pf)

Factors Influencing Capacitance Measurements Frequency Setting o # of times electric field changes direction per second o Low frequency vs. high frequency Cell Growth (Increase in cell diameter) o Can increase capacitance by increase of cell volume Non-biomass solids o Dead cells, oil droplets, debris, gas bubbles o Reduce capacitance by reducing cellular volume fraction 6

Aber Biomass Monitor 200 Instrument Biomass Monitor 200 Head Amplifier Capacitance Probe Cell Culture Mode Frequency set to 580 Khz (Vendor- Recommended) Standardization done in media immediately prior to inoculation Grounding procedure which included a 6 foot head-amp strap that fastens the head amplifier to foot of bioreactor Note that the probe is suitable for bioreactors only and not for shake flask, spinners, or wavebags 7

Implementation Strategy New processes evaluated in pilot & full-scale batches o Technical Development to determine feasibility o Bench-scale experiments using capacitance probe o Pilot-scale, engineering and clinical batches can provide opportunity to assess operational and scalerelated issues Existing processes developed using off-line method o Perform studies to correlate capacitance with offline readings 8

Seed Train Transfers for Batch Process Fixed Time and Variable Transfer Volume o Important to have accurate readings at end of culture Variable Time and Full Transfer Volume o Project target transfer time by leveraging growth rate calculation using two time points during the n- 1 process Variable Time and Partial Transfer Volume o Hybrid of the first and second types 9

Example: Process X Manufacturing Process Process X was developed using offline CEDEX Transferred into Cambridge 2K Manufacturing Facility for Phase 1 Production Resupply Campaign was initiated for Phase 2 Production and Process Validation Campaign Process Overview: o Shake flask inoculum stage, two seed bioreactors, and final fed-batch production bioreactor stage o High viability through seed and production stage o Short production run with low peak VCD o No complex feeding o Seed Transfer: Fixed Time and Variable Volume 10

Example: Process X Manufacturing Process Capacitance data from a total of eight full-scale resupply GMP batches in 2010 showed strong correlation with automated cell counter (CEDEX) 11

Example: Process X Manufacturing Process Methods for measuring VCD were not filed Viability measurements were stated in the filing only at the inoculum and production stage Due to high viabilities demonstrated in clinical batches, discontinuation of viability measurements pose minimal risk to product quality and process performance Proposed maintenance of viability measurements throughout the inoculum shake flask stage (using CEDEX) and a final viability measurement at end of production bioreactor (harvest) 12

Implementation Strategy for Process X Track VCD (vc/ml) of culture using a simple linear regression model that relates capacitance to VCD o One equation for 100L & 750L o Different equation for 2K Created report justifying use of the capacitance probe: 1. State probe as equivalent VCD measuring device 2. Analysis of Fit and Summary of Equations 3. Automation & Engineering Decisions 4. Details of Process Monitoring and Risk Mitigation 13

Example: Process X Manufacturing Process Automation & Engineering Decisions: o Capacitance converted to VCD, displayed on Delta V o Zeroing procedure completed via Delta V o No automation of transfer calculations 14

Example: Process X Manufacturing Process Process Monitoring & Risk Mitigation: o Lack of redundant probe o Probe failure is supplemented by ability to measure offline VCD using CEDEX o Instructions provided in batch record to use offline option 15

Example: Process X Manufacturing Process Normal VCD Trend 100 FVIII_2000L_T1_COMv1 - Unitgroup., Unit -, Sub-Batch _, M1 VCD (vc/ml)_t1 +3 std. dev. Average Batch -3 std. dev. RECD19052-13-003 90 80 70 VCD (vc/ml)_t1 60 50 40 30 20 10 0 M1 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 Days2000L (smoothed and shifted) SIMCA-Batch On-Line Client 3.4.0.3-2013-08-05 10:53:11 (UTC-5) Uniform, Stable, Consistent Within 3SDs of Historical Average (Clinical & Resupply Batches) 16

Example: Process X Manufacturing Process Atypical Probe Behavior (Obvious) 100 90 FVIII_2000L_T1_COMv1 - Unitgroup., Unit -, Sub-Batch _, M1 VCD (vc/ml)_t1 +3 std. dev. Average Batch -3 std. dev. RECD19052-13-014 RECD19052-13-003 80 70 VCD (vc/ml)_t1 60 50 40 30 20 10 0 M1 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 Days2000L (smoothed and shifted) SIMCA-Batch On-Line Client 3.4.0.3-2013-08-05 12:12:03 (UTC-5) Erratic readings due to probe issues Significant offset, operator did not zero the probe prior to inoculation Switch to CEDEX as primary instrument for monitoring 17

Example: Process X Manufacturing Process Atypical Probe Behavior (Non-Obvious) FVIII_2000L_T1_COMv1 - Unitgroup., Unit -, Sub-Batch _, M1 VCD (vc/ml)_t1 +3 std. dev. Average Batch -3 std. dev. RECD19052-12-186 100 90 80 70 VCD (vc/ml)_t1 60 50 40 30 20 10 0 M1 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 Days2000L (smoothed and shifted) SIMCA-Batch On-Line Client 3.4.0.3-2013-08-05 11:13:12 (UTC-5) Non-Routine Offline CEDEX Sample on Day 0 and 1 to confirm results Seed density confirmed low, probe results comparable to CEDEX Continued to use probe as primary instrument for monitoring 18

Summary of Abnormal Trendings Three Common Behaviors of VCD Abnormal Trending: Probe Behavior Type Description and Recommended Course of Action #1 Obvious Erratic or flat-line signal. No fixed course. The trend displays lack of uniformity, regularity or consistency. The VCD probe profile can be within or outside of action limits. Regardless of these results, the CEDEX will be used as a primary instrument since the probe is deemed malfunctioned or problematic. #2 Obvious Significant offset noticed. The VCD probe profile is shifted due to zeroing, calibration or stabilizing issues. The VCD readings typically lie outside the action limit. Use CEDEX as the primary instrument. #3 Non-Obvious Profile is uniform and stable but is inconsistent with previous batches. Non-routine sample required for investigation. 19

20 Process X: Comparison Probe and CEDEX

Summary: Process X Manufacturing Process Capacitance showed consistency and comparability with offline CEDEX Probe performance during PVR and commercial batches were good Created a risk mitigation strategy and identified common atypical VCD trends and proposed course of action 21

Acknowledgements Mark Byers (Manufacturing Sciences) Jeff Simeone (Manufacturing Sciences) Sriram Ramakrishnan (Manufacturing Sciences) John Jewett (Manufacturing) Matt Leprohon (Manufacturing) James Sur (Manufacturing) David Winters (Automation) Barbara Woppmann (Technical Development) Valerie Tsang (Technical Development) Mitch Bennett (Quality) Elijah Tan (Regulatory) 22